Literature DB >> 17459929

Identification of residues critical for the interferon antagonist function of Langat virus NS5 reveals a role for the RNA-dependent RNA polymerase domain.

Gregory S Park1, Keely L Morris, Roselyn G Hallett, Marshall E Bloom, Sonja M Best.   

Abstract

All pathogenic flaviviruses examined thus far inhibit host interferon (IFN) responses by suppressing the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway. Both Langat virus (LGTV; a member of the tick-borne encephalitis virus serogroup) and Japanese encephalitis virus use the nonstructural protein NS5 to suppress JAK-STAT signaling. However, NS5 is also critical to virus replication, contributing methyltransferase and RNA-dependent RNA polymerase (RdRP) activities. The specific amino acid residues of NS5 involved in IFN antagonism are not known. Here, we demonstrate that the LGTV NS5 JAK-STAT inhibitory domain is contained between amino acids 355 and 735 (of 903), a range which lies within the RdRP domain. Furthermore, we identified two noncontiguous stretches of specific amino acids within the RdRP, 374 to 380 and 624 to 647, as critical for inhibition of JAK-STAT signaling. Despite considerable separation on the linear NS5 sequence, these residues localized adjacent to each other when modeled on the West Nile virus RdRP crystal structure. Due to the general conservation of RdRP structures, these results suggest that the specific residues identified act cooperatively to form a unique functional site on the RdRP responsible for JAK-STAT inhibition. This insight into the mechanism underlying flavivirus IFN evasion strategies will facilitate the design of antiviral therapeutics that potentiate the action of IFN during infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17459929      PMCID: PMC1933299          DOI: 10.1128/JVI.02830-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Expression and purification of enzymatically active recombinant RNA-dependent RNA polymerase (NS5) of the flavivirus Kunjin.

Authors:  K J Guyatt; E G Westaway; A A Khromykh
Journal:  J Virol Methods       Date:  2001-03       Impact factor: 2.014

2.  Crystal structure of the dengue virus RNA-dependent RNA polymerase catalytic domain at 1.85-angstrom resolution.

Authors:  Thai Leong Yap; Ting Xu; Yen-Liang Chen; Helene Malet; Marie-Pierre Egloff; Bruno Canard; Subhash G Vasudevan; Julien Lescar
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

3.  Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.

Authors:  A P Durbin; R A Karron; W Sun; D W Vaughn; M J Reynolds; J R Perreault; B Thumar; R Men; C J Lai; W R Elkins; R M Chanock; B R Murphy; S S Whitehead
Journal:  Am J Trop Med Hyg       Date:  2001-11       Impact factor: 2.345

4.  An RNA cap (nucleoside-2'-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization.

Authors:  Marie-Pierre Egloff; Delphine Benarroch; Barbara Selisko; Jean-Louis Romette; Bruno Canard
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

5.  Mutational analysis of bovine viral diarrhea virus RNA-dependent RNA polymerase.

Authors:  V C Lai; C C Kao; E Ferrari; J Park; A S Uss; J Wright-Minogue; Z Hong; J Y Lau
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

6.  Infectious cDNA clones of Langat tick-borne flavivirus that differ from their parent in peripheral neurovirulence.

Authors:  M S Campbell; A G Pletnev
Journal:  Virology       Date:  2000-03-30       Impact factor: 3.616

7.  Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial.

Authors:  Tom Solomon; Nguyen Minh Dung; Bridget Wills; Rachel Kneen; Mary Gainsborough; Tran Vinh Diet; Tran Thi Nhu Thuy; Ha Thi Loan; Vo Cong Khanh; David W Vaughn; Nicholas J White; Jeremy J Farrar
Journal:  Lancet       Date:  2003-03-08       Impact factor: 79.321

8.  The structure of the RNA-dependent RNA polymerase from bovine viral diarrhea virus establishes the role of GTP in de novo initiation.

Authors:  Kyung H Choi; James M Groarke; Dorothy C Young; Richard J Kuhn; Janet L Smith; Daniel C Pevear; Michael G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-19       Impact factor: 11.205

9.  Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection.

Authors:  Ren-Jye Lin; Ching-Len Liao; Elong Lin; Yi-Ling Lin
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  Inhibition of interferon signaling by dengue virus.

Authors:  Jorge L Muñoz-Jordan; Gilma G Sánchez-Burgos; Maudry Laurent-Rolle; Adolfo García-Sastre
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-11       Impact factor: 11.205

View more
  31 in total

1.  West Nile virus infection induces depletion of IFNAR1 protein levels.

Authors:  Jared D Evans; Rachel A Crown; Ji A Sohn; Christoph Seeger
Journal:  Viral Immunol       Date:  2011-08       Impact factor: 2.257

2.  Characterization of Asn130-to-Ala mutant of dengue type 1 virus NS1 protein.

Authors:  Shigeru Tajima; Tomohiko Takasaki; Ichiro Kurane
Journal:  Virus Genes       Date:  2008-02-21       Impact factor: 2.332

3.  The neurovirulence and neuroinvasiveness of chimeric tick-borne encephalitis/dengue virus can be attenuated by introducing defined mutations into the envelope and NS5 protein genes and the 3' non-coding region of the genome.

Authors:  Amber R Engel; Alexander A Rumyantsev; Olga A Maximova; James M Speicher; Brian Heiss; Brian R Murphy; Alexander G Pletnev
Journal:  Virology       Date:  2010-07-01       Impact factor: 3.616

Review 4.  The Many Faces of the Flavivirus NS5 Protein in Antagonism of Type I Interferon Signaling.

Authors:  Sonja M Best
Journal:  J Virol       Date:  2017-01-18       Impact factor: 5.103

5.  A phylogenetic analysis using full-length viral genomes of South American dengue serotype 3 in consecutive Venezuelan outbreaks reveals a novel NS5 mutation.

Authors:  D J Schmidt; B E Pickett; D Camacho; G Comach; K Xhaja; N J Lennon; K Rizzolo; N de Bosch; A Becerra; M L Nogueira; A Mondini; E V da Silva; P F Vasconcelos; J L Muñoz-Jordán; G A Santiago; R Ocazionez; L Gehrke; E J Lefkowitz; B W Birren; M R Henn; I Bosch
Journal:  Infect Genet Evol       Date:  2011-09-23       Impact factor: 3.342

6.  Immune Evasion Strategies Used by Zika Virus to Infect the Fetal Eye and Brain.

Authors:  Branden R Nelson; Justin A Roby; William B Dobyns; Lakshmi Rajagopal; Michael Gale; Kristina M Adams Waldorf
Journal:  Viral Immunol       Date:  2019-11-05       Impact factor: 2.257

7.  Flavivirus Antagonism of Type I Interferon Signaling Reveals Prolidase as a Regulator of IFNAR1 Surface Expression.

Authors:  Kirk J Lubick; Shelly J Robertson; Kristin L McNally; Brett A Freedman; Angela L Rasmussen; R Travis Taylor; Avram D Walts; Seitaro Tsuruda; Mizuki Sakai; Mariko Ishizuka; Elena F Boer; Erin C Foster; Abhilash I Chiramel; Conrad B Addison; Richard Green; Daniel L Kastner; Michael G Katze; Steven M Holland; Antonella Forlino; Alexandra F Freeman; Manfred Boehm; Kentaro Yoshii; Sonja M Best
Journal:  Cell Host Microbe       Date:  2015-07-08       Impact factor: 21.023

8.  Role for conserved residues of sindbis virus nonstructural protein 2 methyltransferase-like domain in regulation of minus-strand synthesis and development of cytopathic infection.

Authors:  Todd W Geders; Janet L Smith; Richard J Kuhn
Journal:  J Virol       Date:  2008-05-21       Impact factor: 5.103

9.  Tick-borne flaviviruses: dissecting host immune responses and virus countermeasures.

Authors:  Shelly J Robertson; Dana N Mitzel; R Travis Taylor; Sonja M Best; Marshall E Bloom
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

10.  Abrogation of TLR3 inhibition by discrete amino acid changes in the C-terminal half of the West Nile virus NS1 protein.

Authors:  Clayton R Morrison; Frank Scholle
Journal:  Virology       Date:  2014-04-03       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.